Successful treatment of porocarcinoma with maxacalcitol and imiquimod

Dermatol Ther. 2019 Mar;32(2):e12830. doi: 10.1111/dth.12830. Epub 2019 Feb 7.

Authors

Tomoya Nagasawa¹, Akiko Hirata², Shiro Niiyama¹, Yasunori Enomoto³, Hidetsugu Fukuda¹

Affiliations

¹ Department of Dermatology, Toho University Ohashi Medical Center, Tokyo, Japan.
² Department of Plastic and Reconstructive Surgery, Toho University Ohashi Medical Center, Tokyo, Japan.
³ Department of Pathology, Toho University Ohashi Medical Center, Tokyo, Japan.

PMID: 30659720
DOI: 10.1111/dth.12830

Abstract

This is the first report of a case of porocarcinoma that was successfully treated with maxacalcitol and imiquimod.

Keywords: contact immunotherapy; regression; vitamin D.

© 2019 Wiley Periodicals, Inc.

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antineoplastic Agents / administration & dosage
Calcitriol / administration & dosage
Calcitriol / analogs & derivatives*
Eccrine Porocarcinoma / drug therapy*
Eccrine Porocarcinoma / pathology
Female
Humans
Imiquimod / administration & dosage*
Sweat Gland Neoplasms / drug therapy*
Sweat Gland Neoplasms / pathology
Treatment Outcome

Substances

Antineoplastic Agents
Calcitriol
maxacalcitol
Imiquimod